RenaRuiyaXianMD

Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology

Physician

Dr. Xian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1800 Orleans Street
Baltimore, MD 21287
Phone+1 410-955-5000

Fax+1 410-955-5001

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Molecular Genetic Pathology, 2014 - 2015
Johns Hopkins UniversityFellowship, Hematopathology, 2013 - 2014
University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 2009 - 2013
Northwestern University The Feinberg School of MedicineClass of 2009

PubMed

1 citations
Diagnostic and Prognostic/Therapeutic Significance of Comprehensive Analysis of Bone and Soft Tissue Tumors Using Optical Genome Mapping and Next-Generation Sequencing.
Jen Ghabrial, Victoria Stinnett, Efrain Ribeiro, Melanie Klausner, Laura Morsberger
Modern Pathology. 2024-12-13
Genomic Reporting Practices Across 5 Molecular Disciplines: A Study From the College of American Pathologists.
Larissa V Furtado, Annette S Kim, Ann M Moyer, Joel T Moncur, Rena R Xian
Archives of Pathology & Laboratory Medicine. 2024-11-22
The Era of Molecular Hematopathology: Back to the Future.
Pawel Mroz, Mark D Ewalt, Susan E Harley, Patricia C Tsang, Rena R Xian
The Journal of Molecular Diagnostics. 2024-11-01

Journal Articles

Clinical Validation of Coexisting Driver Mutations in Colorectal Cancers
Junaid Ibrahim, James R Eshleman, Gang Zheng, Christopher D Gocke, Rena Xian, ScienceDirect

Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing–Based Hematologic Malignancy Assays with Survey Material–Specific Differences in Variant FrequenciesJanuary 2020
Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing–Based Hematologic Malignancy Assays with Survey Material–Specific Differences in Variant FrequenciesJanuary 2020